T-cell receptor γδ T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a postthymic immunophenotype

被引:18
作者
Sugimoto, T
Imoto, S
Matsuo, Y
Kojima, K
Yasukawa, M
Murayama, T
Kohfuku, J
Mizuno, I
Yakushijin, K
Sada, A
Nishimura, R
Koizumi, T
机构
[1] Hyogo Med Ctr Adults, Clin Res Inst, Hyogo, Japan
[2] Hyogo Med Ctr Adults, Div Hematol & Oncol, Hyogo, Japan
[3] Hyogo Med Ctr Adults, Dept Lab Med, Hyogo, Japan
[4] Hayashibara Biochem Labs Inc, Fujisaki Cell Ctr, Okayama, Japan
[5] Okayama Univ, Sch Med, Dept Internal Med, Okayama 700, Japan
[6] Ehime Univ, Sch Med, Dept Internal Med, Matsuyama, Ehime, Japan
关键词
T-cell prolymphocytic leukemia; postthymic T-cell; T-cell receptor gamma delta;
D O I
10.1007/s00277-001-0381-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
T-cell prolymphocytic leukemia (T-PLL) is a postthymic T-cell neoplasm with a characteristic morphology and heterogeneous immunophenotype. Most cases of T-PLL express membrane T-cell receptors (TCRs) of the alphabeta phenotype. We experienced a 30-year-old man suffering from TCRgammadelta T-cell leukemia with morphology compatible to T-PLL with a postthymic phenotype. He was admitted with skin eruption and pancytopenia. Peripheral blood and bone marrow were occupied with medium-sized lymphocytes, which had moderately condensed chromatin with a single nucleolus and sparse, nongranular basophilic cytoplasm. The immunophenotype was CD1a(-), CD2(-), CD3(+), CD4(-), CD5(+), CD7(+), CD8(-), and terminal deoxynucleotidyl transferase negative. Hepatosplenomegaly was absent. He was diagnosed as having T-PLL and was treated with combination chemotherapy. Six months later the leukemic cell became chemoresistant. Although the patient showed transient improvement in response to pentostatin, he died 13 months after the diagnosis. To our knowledge, this is the first case of T-PLL with a TCRgammadelta phenotype.
引用
收藏
页码:749 / 751
页数:3
相关论文
共 15 条
[11]  
MATUTES E, 1991, BLOOD, V78, P3269
[12]   Similarities between T-cell chronic lymphocytic leukemia and the small-cell variant of T-prolymphocytic leukemia [J].
Matutes, E ;
Catovsky, D .
BLOOD, 1996, 87 (08) :3520-3520
[13]   THE ROLE OF PENTOSTATIN IN THE TREATMENT OF T-CELL MALIGNANCIES - ANALYSIS OF RESPONSE RATE IN 145 PATIENTS ACCORDING TO DISEASE SUBTYPE [J].
MERCIECA, J ;
MATUTES, E ;
DEARDEN, C ;
MACLENNAN, K ;
CATOVSKY, D .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (12) :2588-2593
[14]  
Shichishima T, 2000, BRIT J HAEMATOL, V108, P397
[15]   Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor αβ lineage [J].
Szczepanski, T ;
Pongers-Willemse, MJ ;
Langerak, AW ;
Harts, WA ;
Wijkhuijs, AJM ;
van Wering, ER ;
van Dongen, JJM .
BLOOD, 1999, 93 (12) :4079-4085